nodummy, the terms of Asher notes, exhibits and schedules thereof are all clearly notated in MINE's 10K and Q. We are quite aware that the O/S has increased about 600 million shares due to Asher conversions. We are also aware that they can get an opinion letter from an attorney to work around Rule 144 holding period. Asher is actually getting a 45% discount. MINE will most likely see yet another increase in O/S, no one denies this as they will need the cash for production.
Sure, Asher and Kramer brothers have a bad rep for killing small issuers but do smaller/start-ups have a better alternative? The alternative is not to borrow from Asher, isn't it then? It goes both ways.
Oh but don't think that MINE is innocent in all of this. True they are too much of a failed company to qualify for financing, but MINE is very complicit in all of this putting out several press releases to sucker in retail investors while they issues millions upon millions of free trading shares to Asher to be dumped on those very same retail investors.
I would not necessarily call it complicit as I think that is a strong word. That would be like saying shareholders should not receive any update to ensure Asher does not get to unload their shares. I believe updates of their development as long as they are indeed achieving milestones are fine. Big board issuers do it all the time, and biotechs are the worst of them releasing big news against a D sale...
Sierra...lol...Guy follows and pumps stocks that are trending and has no clue what most of them does. Hence the "buyout/merger" repeater band on most of what's being touted if I'm being nice.